U. Divisekera

Immobilization and surface characterization of NeutrAvidin biotin-binding protein on different hydrogel interlayers.

H. Griesser, T. Gengenbach, L. Meagher, 2003, Journal of colloid and interface science.

Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy

S. Loi, M. Smyth, H. Duret, 2011, Proceedings of the National Academy of Sciences.

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

M. Smyth, U. Divisekera, D. Denoyer, 2010, Proceedings of the National Academy of Sciences.

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

M. Smyth, P. Darcy, P. Beavis, 2013, Proceedings of the National Academy of Sciences.

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.

M. Smyth, P. Darcy, H. Duret, 2011, Cancer research.

Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes

A. Strasser, H. Puthalakath, T. Kataoka, 2004, Cell Death and Differentiation.

CD73-deficient mice are resistant to carcinogenesis.

A. Möller, M. Smyth, P. Darcy, 2012, Cancer research.

Microenvironment and Immunology CD 73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis

M. Smyth, P. Darcy, H. Duret, 2011 .